TGFBR2 KO CAR27/IL-15 NK cells
/ UT MD Anderson Cancer Center
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 04, 2026
Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
(clinicaltrials.gov)
- P1 | N=60 | Not yet recruiting | Sponsor: M.D. Anderson Cancer Center
New P1 trial • Pan tumor • Hematological Malignancies • Lymphoma • Oncology • ABL1 • BCR
1 to 1
Of
1
Go to page
1